Hjem › Ulcerøs colitis › Texas › Lubbock
Ulcerøs colitis kliniske forsøg i Lubbock, TX
9 studier for Ulcerøs colitis søger deltagere på steder i og omkring Lubbock (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruttererFase 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekruttererFase 4
- West Texas Research Institute, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
- Xencor Investigative Site, Lubbock
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
- Site US-015, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruttererFase 2
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekruttererFase 2
- Mirador Therapeutics Selected Site, Lubbock
Ulcerøs colitis forsøg i andre byer
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- San Antonio, TX16 studier
- Tacoma, WA15 studier
- Chicago, IL15 studier
- San Diego, CA15 studier
- Tyler, TX14 studier
- Colorado Springs, CO14 studier
- Los Angeles, CA13 studier
- St. Louis, MO13 studier
Andre studier i Lubbock
- Crohns sygdom10 studier
- Brystkræft6 studier
- Ikke-småcellet lungecancer4 studier
- Psoriasisartrit3 studier
- Slagtilfælde3 studier
- Overvægt3 studier
- Overvægt3 studier
- Inflammatorisk tarmsygdom3 studier
- Burkitts lymfom3 studier
- Multipelt myelom3 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.